Daiichi Sankyo and AstraZeneca’s Enhertu snubbed by UK’s NICE for third time
Charity Breast Cancer Now has described the failure to negotiate a fair price of Enhertu as “utterly heartbreaking”.
Metastatic Colorectal Cancer Market Forecast to Reach US$ 9,787.5 Million by 2034, Growing at 5.1% CAGR | Fact.MR Report
Global Metastatic Colorectal Cancer Market to Record Stellar Growth with Advancements in Treatments and Rise in Healthcare InfrastructuresRockville, MD, Nov. 20, 2024 (GLOBE NEWSWIRE) -- According to ...